Merck Announces Emerging Biotech Grant Program Winners
01 Nov 2024 //
PRESS RELEASE
Merck Invests €70M To Expand ADC Manufacturing For Cancer Care
29 Oct 2024 //
PRESS RELEASE
Merck Opens €290M Biosafety Testing Site In Rockville, USA
09 Oct 2024 //
PRESS RELEASE
Merck Launches Single-Use Reactor For Antibody Drug Conjugates
10 Sep 2024 //
PRESS RELEASE
Merck Earns EXCiPACT Certification For Cell Culture Media
03 Sep 2024 //
PRESS RELEASE
Merck Acquires Mirus Bio To Expand Viral Vector Bioprocessing
01 Aug 2024 //
PRESS RELEASE
Merck Starts GMP Cell Culture Media Manufacturing In China
12 Jul 2024 //
PRESS RELEASE
Merck Signs MoU For Gene Therapy To Treat Parkinson’s Disease
11 Jul 2024 //
PRESS RELEASE
Merck Partners With Afrigen On mRNA Vaccine Tech Development
03 Jul 2024 //
PRESS RELEASE
Merck And Fox Foundation Offer Service To Advance Parkinson`s Research
18 Jun 2024 //
PRESS RELEASE
Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany
11 Jun 2024 //
PRESS RELEASE
Merck Completes €180M Expansion Of Schnelldorf Distribution Center
06 Jun 2024 //
PRESS RELEASE
Merck Names Siren Biotechnology As North American Advance Biotech Grant Winner
04 Jun 2024 //
PRESS RELEASE
Merck Introduces Software For Complete Data Traceability In Microbial QC
28 May 2024 //
PRESS RELEASE
MilliporeSigma To Acquire Mirus Bio For Viral Vector Manufacturing
22 May 2024 //
PRESS RELEASE
Merck Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
17 Apr 2024 //
PRESS RELEASE
Merck Launches All-In-One Genetic Stability Assay For Faster Biosafety Testing
16 Apr 2024 //
PRESS RELEASE
Merck Invests €300M+ In New Life Science Production Site In Korea
30 Mar 2024 //
PRESS RELEASE
Merck Expands M Lab™ Collaboration Center in Shanghai
26 Mar 2024 //
PRESS RELEASE
Merck Opens New € 20 Million Distribution Center in Brazil
27 Feb 2024 //
PRESS RELEASE
Merck Signs MoU With Mycenax Biotech For Bioprocessing Tech Innovation
24 Jan 2024 //
PRESS RELEASE
MilliporeSigma`s Global Food Drive Provides 535,685 Meals
10 Jan 2024 //
ACCESSWIRE
MilliporeSigma Employee Ignites Passion for Science
12 Dec 2023 //
ACCESSWIRE
MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery
05 Dec 2023 //
PR NEWSWIRE
MilliporeSigma`s Newest Plan To Reduce the Impact of Packaging
01 Nov 2023 //
ACCESSWIRE
MilliporeSigma To Host Upcoming Change Chemistry Event
16 Oct 2023 //
ACCESSWIRE
MilliporeSigma Partner Beyond Benign Launches New Green Chemistry Teaching
10 Oct 2023 //
ACCESSWIRE
MilliporeSigma christens €28M pair of mRNA production plants
27 Sep 2023 //
FIERCE PHARMA
MilliporeSigma Leaders Receive Business Intelligence Group Sustainability Awards
18 Sep 2023 //
ACCESSWIRE
MilliporeSigma’s Dustin Andre Named a GreenBiz 30 Under 30 Honoree
14 Sep 2023 //
ACCESSWIRE
MilliporeSigma budgets $25M to expand dry powder cell operations
13 Jul 2023 //
FIERCE PHARMA
Merck to expand reagent production capacity in China
30 Jun 2023 //
INDIAN PHARMA POST
Curia Expands Cell Line Development Offering with CHOZN Platform
20 Jun 2023 //
PRESS RELEASE
MilliporeSigma Partners With ISP to Spark Passion for STEM Learning Worldwide
07 Jun 2023 //
ACCESSWIRE
MilliporeSigma Announces Proteologix as Winner of NA Advance Biotech Grant
06 Jun 2023 //
PR NEWSWIRE
MilliporeSigma Invests €35M in Biosafety Testing in Scotland
02 Jun 2023 //
CONTRACT PHARMA
Merck: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
31 May 2023 //
PRESS RELEASE
Merck Kicks Off 2023 Curiosity Cube Mobile Lab Tour
26 Apr 2023 //
PRESS RELEASE
Lotte Biologics USA Signs LOI with Merck MilliporeSigma
26 Apr 2023 //
PRESS RELEASE
Merck Launches Ultimus® Film to Offer Superior Strength
24 Apr 2023 //
PRESS RELEASE
MilliporeSigma Ranks on EPA’s National Top 100 List of Green Power Users
24 Apr 2023 //
ACCESSWIRE
Merck Announces Expanded Partnership with Beyond Benign
27 Mar 2023 //
PRESS RELEASE
MilliporeSigma Opens Commercial Facility for New CTDMO Services
04 Oct 2022 //
CONTRACTPHARMA
MilliporeSigma launches new AAV platform
11 Aug 2022 //
ENDPOINTS NEWS
MilliporeSigma Breaks Ground on First Lateral Flow Membrane Production Facility
18 Jul 2022 //
PRNEWSWIRE
MilliporeSigma to help Lotte stand up biologics production biz
01 Jul 2022 //
FIERCEPHARMA
MilliporeSigma opens $65M high-potency API facility
28 Jun 2022 //
FIERCEPHARMA
MilliporeSigma looks to keep up with the competition in new Wisconsin expansion
23 Jun 2022 //
ENDPTS
MilliporeSigma Acquires MAST Platform from Lonza
06 Apr 2022 //
PRESS RELEASE
MilliporeSigma Closes Exelead Acquisition, Plans to Invest More Than € 500M
23 Feb 2022 //
PRNEWSWIRE
Biden inks $137 mln contract to boost supply of key material for COVID tests
30 Dec 2021 //
REUTERS
MilliporeSigma Announces New Innovation & Capacity for Next Gene ADC Therapies
28 Oct 2021 //
BIOSPACE
MilliporeSigma Launches New Tech and Expanded ADC Capacity
28 Oct 2021 //
CONTRACTPHARMA
New Merck KGgA viral vector CDMO plant opens in California
13 Oct 2021 //
BIOPHARMA-REPORTER
MilliporeSigma Opens Second Facility in Carlsbad
13 Oct 2021 //
CONTRACTPHARMA
MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid Demand
25 May 2021 //
CONTRACTPHARMA
MilliporeSigma Accelerates European Expansion Plans for Single-use Products
17 Mar 2021 //
PRNEWSWIRE
MilliporeSigma Launches Lentiviral Production Platform for Cell & Gene Therapies
16 Oct 2020 //
PHARMTECH
MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant
08 Oct 2020 //
PRNEWSWIRE
Merck KGaA`s MilliporeSigma pumps $65M for next-generation oncology meds
09 Sep 2020 //
FIERCE PHARMA